DNA Capital
Status
ACTIVE
Global HQ
United States
Countries of investment
- USA
- Brazil
Investment stages
- Seed
- Series A
- Series B
Industries
- Health tech
- Biotechnology
- AI
- Fintech
About
DNA Capital collaborates with visionary founders and experienced management teams to strategically invest in early-stage healthcare and healthtech companies. Our mission is to cultivate and scale innovative businesses that emphasize high-quality, ethical, and humane solutions, addressing pressing challenges within the healthcare industry. By fostering a supportive ecosystem, DNA Capital aims to drive transformative advancements that enhance patient care and promote overall well-being. Through our commitment to excellence, we strive to create lasting impact and sustainable growth in the health sector.
DNA Capital collaborates with visionary founders and experienced management teams to strategically invest in early-stage healthcare and healthtech companies. Our mission is to cultivate and scale innovative businesses that emphasize high-quality, ethical, and humane solutions, addressing pressing challenges within the healthcare industry. By fostering a supportive ecosystem, DNA Capital aims to drive transformative advancements that enhance patient care and promote overall well-being. Through our commitment to excellence, we strive to create lasting impact and sustainable growth in the health sector.
Investment Thesis
DNA Capital invests in healthcare and life sciences companies, focusing on innovations in digital health, biotechnology, and healthcare services. Their investment thesis centers on identifying businesses that leverage technology to improve patient care, enhance operational efficiency, and deliver measurable healthcare outcomes. DNA Capital seeks companies with scalable solutions, strong leadership, and significant potential for growth and market impact.